An Innovative Canadian Pharmaceutical Company

Revenue Projected at $150,000,000 by 2025

Sponsored
Message: INTERVIEW ALERT: Valeo Pharma (VPH: CSE) (VPHIF: OTCQB)

$25,000,000 Financing - NON DILUTIVE

$VPH $VPH.ca raised $25M in oversubscribed round from: * Syndicate led by Desjardins Capital Markets * Investissement Qu├ębec WHY? * 9month revenues $10.2M + 94% * Partnership with likes of

INTERVIEW OUT SOON!

Share
New Message
Please login to post a reply